Statistics for Golden Ally Lifetech Group (id:11157 AQPW)
Valuation metrics
Market cap
2.00B
Enterprise value
2.00B
Trailing P/E (ttm)
-376.78
Forward P/E
PEG ratio
-0.03
Price/Sales (ttm)
Price/Book (mrq)
2.20K
Enterprise Value/Revenue
Enterprise Value/EBITDA
-330.90
Overview
Shares outstanding
7.41B
Float
920.59M
Shares short
% Held by insiders
0.88%
% Held by institutions
0.00%
Average volume (10 days)
140.00
Average volume (90 days)
Price summary
52-Week low
0.27
52-Week high
0.27
52-Week change
0.00%
Beta
0.84
50-Day moving average
0.27
200-Day moving average
0.27
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2022
Most recent quarter (mrq)
March 31th, 2023
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-89.08%
Return on equity
-149.24%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-6,537,416.00
Diluted EPS (ttm)
0.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
191.04K
Total cash per share (mrq)
0.00
Total debt (mrq)
83.80K
Total Debt/Equity (mrq)
9.22
Current ratio (mrq)
324.40%
Book value per share (mrq)
0.00
Cash flow
Cash flow statement
-4,419,489.00
Levered free cash flow (LFCF)
-2,639,339.00